A Glimpse Into The Expert Outlook On Cross Country Healthcare Through 4 Analysts
Portfolio Pulse from Benzinga Insights
Cross Country Healthcare (NASDAQ:CCRN) has been evaluated by 4 analysts over the last three months, showing a mix of bullish to indifferent sentiments. The average 12-month price target is now $20.00, down from $23.25, with recent actions including lowered price targets by analysts from Benchmark and Barrington Research, and Truist Securities. The company's financial overview indicates a negative revenue trend with a -34.09% growth, yet it maintains strong net margin, ROE, and ROA figures, alongside a low debt-to-equity ratio.
May 02, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cross Country Healthcare's stock may face short-term pressure due to the lowered average price target and negative revenue trend, but strong financial health indicators could mitigate some concerns.
The lowered price targets and negative revenue growth are likely to impact investor sentiment negatively in the short term. However, the company's strong net margin, ROE, ROA, and low debt-to-equity ratio suggest a solid financial foundation, which might help in stabilizing the stock price over time.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100